As of 2026-04-05, the Intrinsic Value of Abivax SA (ABVX.PA) is -15.65 EUR. This ABVX.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 101.40 EUR, the upside of Abivax SA is -115.43%.
Based on its market price of 101.40 EUR and our intrinsic valuation, Abivax SA (ABVX.PA) is overvalued by 115.43%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -15.65 - -15.65 | -15.65 | -115.43% |
| P/E | (8.39) - (20.47) | (14.94) | -114.7% |
| DDM - Stable | (25.40) - (150.09) | (87.75) | -186.5% |
| DDM - Multi | (16.39) - (79.20) | (27.58) | -127.2% |
| Market Cap (mil) | 8,027.84 |
| Beta | 1.21 |
| Outstanding shares (mil) | 79.17 |
| Enterprise Value (mil) | 8,112.84 |
| Market risk premium | 5.82% |
| Cost of Equity | 9.25% |
| Cost of Debt | 5.00% |
| WACC | 9.18% |